Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × INDUSTRY × Gastrointestinal Toxicity × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Gastrointestinal 1

Conditions

Breast Neoplasms 169 Neoplasms 127 Prostatic Neoplasms 91 Lung Neoplasms 83 Colorectal Neoplasms 78 Leiomyoma 37 Pancreatic Neoplasms 36 Carcinoma, Hepatocellular 36 Lymphoma, Follicular 35 Carcinoma, Non-Small-Cell Lung 30 Neoplasm Metastasis 27 Skin Neoplasms 26 Colonic Neoplasms 26 Uterine Cervical Neoplasms 25 Liver Neoplasms 25 Multiple Myeloma 23 Head and Neck Neoplasms 22 Glioblastoma 22 Barrett Esophagus 21 Polycystic Ovary Syndrome 19 Brain Neoplasms 18 Urinary Bladder Neoplasms 17 Polyps 16 Ovarian Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 14 Rectal Neoplasms 14 Esophageal Neoplasms 14 Carcinoma, Squamous Cell 14 Carcinoma, Basal Cell 14 Adenoma 14

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02351089 2020-03-05

ProRad

Probi AB

Phase NA Terminated

GastrointestinalGynecologic

Gastrointestinal Toxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡